You are a chemist. Please follow the instructions to convert the structure to the corresponding name.
system
For the molecule named (3S,4R)-N-cyclohexyl-1-[5-fluoro-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-3-methoxypiperidin-4-amine;(3S,4R)-N-cyclohexyl-3-methoxy-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinoxalin-2-yl]piperidin-4-amine;(3S,4R)-N-(4,4-difluorocyclohexyl)-3-methoxy-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;1-[6-ethyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-[(2R)-3-methylbutan-2-yl]piperidin-4-amine;(3R,4S)-3-methoxy-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;N-[6-methyl-2-[4-[[(2R)-3-methylbutan-2-yl]amino]piperidin-1-yl]quinoline-3-carboximidoyl]acetamide by IUPAC nomenclature, provide its molecular formula.
user
C144H190F3N31O11
assistant